Comparison of risk stratification tools in predicting outcomes of patients with higher-risk myelodysplastic syndromes treated with azanucleosides

類似資料

• Comparing the prognostic value of risk stratifying models for patients with lower-risk myelodysplastic syndromes: Is one model better?
  著者:: Zeidan, Amer M., 等
  出版事項: (2015)
• Outcomes of patients with myelodysplastic syndromes who achieve stable disease after treatment with hypomethylating agents
  著者:: Nazha, Aziz, 等
  出版事項: (2015)
• The efficacy of current prognostic models in predicting outcome of patients with myelodysplastic syndromes at the time of hypomethylating agent failure
  著者:: Nazha, Aziz, 等
  出版事項: (2016)
• Validation of International Working Group response criteria in higher‐risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research Consortium
  著者:: Komrokji, Rami S., 等
  出版事項: (2020)
• Genomic Biomarkers to Predict Resistance to Hypomethylating Agents in Patients With Myelodysplastic Syndromes Using Artificial Intelligence
  著者:: Nazha, Aziz, 等
  出版事項: (2019)